Comment from American Pharmacists Association
AnonymousOpposeTrade association
Summary: The American Pharmacists Association (APhA) opposes the proposed action, arguing that it could undermine the integrity of the Vaccine Injury Compensation Program (VICP). They emphasize that the VICP provides essential liability protection for pharmacists and ensures a stable vaccine supply, warning that changes to eligibility criteria could increase unsubstantiated claims and diminish patient access to immunizations.
Dear Dockets Management Staff,
The American Pharmacists Association (APhA) appreciates the opportunity to provide FDA comments on the importance of maintaining the integrity of the Vaccine Injury Compensation Program (VICP) and the critical role that pharmacists and those under their supervision have in vaccinating patients nationwide.
APhA represents pharmacists, student pharmacists, and pharmacy technicians in all practice settings, including but not limited to community pharmacies, hospitals, long-term care facilities, specialty pharmacies, community health centers, physician offices, ambulatory clinics, managed care organizations, hospice settings, and government facilities. Our members strive to improve medication use, advance patient care, and enhance public health.
Full comments are attached.